妊娠期肠道超声显示活动性炎症性肠病与不良妊娠及新生儿结局风险增加相关,且独立于临床和生化疾病活动度
这项国际前瞻性队列研究于2017至2023年从3个专科IBD妊娠服务机构招募377例妊娠IBD患者,其中234人在妊娠期接受肠道超声检查。结果显示,妊娠中期肠道超声显示肠壁厚度>6 mm与早产风险增加4倍、低出生体重风险增加2倍相关,充血与子痫前期风险增加3倍相关,肠壁厚度每增加1 mm与妊娠期糖尿病风险增加相关,且独立于临床活动和粪钙卫蛋白。
要点
- 妊娠中期肠道超声肠壁厚度>6 mm与早产风险RR 4.01及低出生体重风险RR 2.19相关。
- 妊娠中期肠道超声充血与子痫前期风险RR 3.46相关。
- 临床评分与肠道超声或粪钙卫蛋白活动度一致性弱,尤其克罗恩病。
核心结论
- 妊娠期肠道超声显示的活动性IBD与不良妊娠结局风险增加相关,独立于临床活动度和粪钙卫蛋白。
- 作者认为应考虑使用肠道超声监测妊娠期IBD以指导治疗决策。
研究设计与样本
- 国际前瞻性队列研究,2017至2023年从3个专科IBD妊娠服务机构招募377例妊娠IBD患者,其中198例为克罗恩病。
- 参与者在妊娠早期、中期、晚期及产后6周接受临床评估和粪钙卫蛋白检测,在转诊时间允许时于早期或中期进行肠道超声检查。
- 采用单变量和多变量对数二项回归分析评估肠道超声活动度对妊娠结局的影响,采用Cohen κ系数确定粪钙卫蛋白、肠道超声与临床疾病活动度之间的一致性。
主要发现
- 234名女性在妊娠期接受了肠道超声检查。
- 妊娠中期肠壁厚度>6 mm与早产风险增加4倍相关(RR 4.01,95%CI 1.26-12.72,P=.018),与低出生体重风险增加2倍相关(RR 2.19,95%CI 1.01-4.72,P=.046)。
- 妊娠中期肠道超声充血与子痫前期风险增加3倍相关(RR 3.46,95%CI 1.03-11.12,P=.046)。
- 妊娠中期肠壁厚度每增加1 mm估计与妊娠期糖尿病风险增加相关(RR 1.08,95%CI 1.088-1.089,P<.001)。
- 妊娠期临床活动度(Harvey Bradshaw指数或简单临床结肠炎活动指数)与肠道超声或粪钙卫蛋白活动度之间一致性弱,尤其对于克罗恩病。
临床怎么用
- 作者认为应考虑使用肠道超声监测妊娠期IBD以指导治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Clinically active inflammatory bowel disease (IBD) is associated with an increased risk of adverse pregnancy outcomes. However, the validity of clinical scores to assess antenatal disease activity is questionable. We aimed to assess whether active disease defined by intestinal ultrasound (IUS) may predict adverse pregnancy outcomes. METHODS: This international prospective cohort study recruited pregnant individuals with IBD from 2017 to 2023 from 3 specialist IBD pregnancy services. Participants underwent clinical assessments and fecal calprotectin (FCP) testing in the first (T1), second (T2), and third (T3) trimesters, and 6 weeks postpartum. IUS was performed in T1 or T2 when referral timing allowed. Univariable and multivariable log-binomial regression analyses were used to estimate the impact of IUS activity on pregnancy outcomes. Cohen's κ coefficients were used to determine agreement between FCP, IUS, and clinical disease activity. RESULTS: The study recruited 377 participants, 198 with Crohn's disease (CD), and 234 women underwent an IUS during pregnancy. A maximal bowel wall thickness (BWT) >6 mm in T2 was associated with a 4-fold increased risk of prematurity (relative risk [RR], 4.01; 95% confidence interval [CI], 1.26-12.72; P = .018) and 2-fold increased risk of low-birth-weight delivery (RR, 2.19; 95% CI. 1.01-4.72; P = .046). Hyperemia on IUS in T2 was associated with a 3-fold increase in preeclampsia risk (RR, 3.46; 95% CI, 1.03-11.12; P = .046). Each 1-mm increase in BWT in T2 was estimated to increase the risk of gestational diabetes (RR, 1.08; 95% CI, 1.088-1.089; P < .001) Agreement between clinical (Harvey Bradshaw index or Simple Clinical Colitis Activity Index) and IUS/FCP activity during pregnancy was weak, particularly for CD. CONCLUSIONS: Active IBD on IUS in pregnancy is associated with an increased risk of adverse pregnancy outcomes, independent of clinical activity and FCP. Use of IUS monitoring antenatally should be considered to guide therapeutic decision-making.
引用
- Prentice RE, Flanagan EK, Wright EK, et al. Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease Activity. Gastroenterology. 2025. PMID: 40147617. doi:10.1053/j.gastro.2025.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。